<i>Candida auris</i>-associated hospitalizations and outbreaks, China, 2018–2023

The emerging human fungal pathogen <i>Candida auris</i> has become a serious threat to public health. This pathogen has spread to 10 provinces in China as of December 2023. Here we describe 312 <i>C. auris</i>-associated hospitalizations and 4 outbreaks in healthcare settings in China from 2018 to 2023. Three genetic clades of <i>C. auris</i> have been identified during this period. Molecular epidemiological analyses indicate that <i>C. auris</i> has been introduced and local transmission has occurred in multiple instances in China. Most <i>C. auris</i> isolated from China (98.7%) exhibited resistance to fluconazole, while only a small subset of strains were resistant to amphotericin B (4.2%) and caspofungin (2.2%).